NATR · Nature's Sunshine Products Inc. Common Stock
View on chartInsiders & Stakes
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10% Owner | ▲ Buy | Open Market | 1,924,486 Shares held | 8/10/2026 | View profile |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% Owner | ▲ Buy | Open Market | 1,699,139 Shares held | 9/15/2022 | View profile |
| Terrence Moorehead President and CEO | ▼ Sell | Tax Withholding | 543,292 Shares held | 7/21/2025 | View profile |
| MESDAG WILLEM Director | ▼ Sell | Other | 524,997 Shares held | 9/15/2021 | View profile |
| BATY JOSEPH W EVP & Chief Financial Officer | ▲ Buy | Grant | 173,702 Shares held | 7/21/2022 | View profile |
| Kenneth G. Romanzi Chief Executive Officer | ▲ Buy | Grant | 143,999 Shares held | 5/15/2026 | View profile |
| Leslie Shane Jones EVP & Chief Financial Officer | ▼ Sell | Tax Withholding | 104,658 Shares held | 5/5/2026 | View profile |
| Bryant J. Yates EVP & President, Europe | ▼ Sell | Open Market | 77,446 Shares held | 6/5/2026 | View profile |
| Gonzalez Martin A. EVP, Global Supply Chain | ▼ Sell | Tax Withholding | 69,640 Shares held | 11/4/2025 | View profile |
| Comstock Tracee VP, Human Resources | ▼ Sell | Tax Withholding | 64,449 Shares held | 7/21/2025 | View profile |
| Robert D. Straus Director | ▲ Buy | Grant | 56,514 Shares held | 5/15/2026 | View profile |
| Teets John Christopher Director | ▲ Buy | Grant | 55,315 Shares held | 5/6/2024 | View profile |
| Silcock Edward EVP & President, North America | ▲ Buy | Grant | 51,486 Shares held | 7/21/2022 | View profile |
| Jonathan David Lanoy SVP, Finance - Interim CFO | ▲ Buy | Grant | 48,392 Shares held | 5/15/2026 | View profile |
| SPRINGER MARY BETH Director | ▲ Buy | Grant | 48,352 Shares held | 5/4/2022 | View profile |
| Daniel C. Norman EVP & President, Asia | ▼ Sell | Open Market | 47,276 Shares held | 6/1/2026 | View profile |
| Kevin R. Herbert EVP & President, North America | ▼ Sell | Tax Withholding | 46,890 Shares held | 6/26/2026 | View profile |
| Nathan G. Brower EVP, General Counsel | ▼ Sell | Open Market | 43,438 Shares held | 5/21/2026 | View profile |
| Heidi Wissmiller Director | ▲ Buy | Grant | 41,667 Shares held | 5/15/2026 | View profile |
| MOSS RICHARD D Director | ▲ Buy | Grant | 38,629 Shares held | 5/6/2024 | View profile |
| Rong Yang Director | ▲ Buy | Grant | 34,749 Shares held | 5/15/2026 | View profile |
| Curtis Kopf Director | ▲ Buy | Grant | 34,427 Shares held | 5/15/2026 | View profile |
| Tess Roering Director | ▲ Buy | Grant | 34,427 Shares held | 5/15/2026 | View profile |
| Kevin Gregory Fuller Global Chief Marketing Officer | ▲ Buy | Grant | 31,548 Shares held | 5/15/2026 | View profile |
| Crockett Sarah Chief Marketing Officer | ▲ Buy | Grant | 26,873 Shares held | 3/11/2024 | View profile |
| Erich A. Fritz EVP-Chief Supply Chain Officer | ▲ Buy | Grant | 20,889 Shares held | 5/15/2026 | View profile |
| Steven J. Fasching Chief Financial Officer | ▲ Buy | Grant | 15,369 Shares held | 5/15/2026 | View profile |
| Katie May | ▲ Buy | Grant | 14,266 Shares held | 5/15/2026 | View profile |
| Wu Shirley Director | ▲ Buy | Grant | 9,149 Shares held | 5/4/2022 | View profile |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 10% Owner | ▼ Sell | Open Market | 0 Shares held | 6/27/2025 | View profile |
Transaction History
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 16,928 | $267K | 8/10/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 13,072 | $206K | 8/10/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 10,000 | $160K | 8/10/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 876 | $14K | 8/10/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 10,000 | $165K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 1,000 | $16K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 20,000 | $331K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 5,000 | $83K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 30,000 | $500K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 20,000 | $334K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 10,000 | $167K | 8/7/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 2,000 | $33K | 8/6/2026 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | ▲ Buy | Open Market | 2,513 | $42K | 8/6/2026 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 1,976 | $42K | 6/26/2026 |
| Kevin R. Herbert | ▼ Sell | Open Market | 1,134 | $23K | 6/12/2026 |
| Kevin R. Herbert | ▼ Sell | Open Market | 866 | $18K | 6/12/2026 |
| Bryant J. Yates | ▼ Sell | Open Market | 11,968 | $238K | 6/5/2026 |
| Daniel C. Norman | ▼ Sell | Open Market | 9,713 | $200K | 6/1/2026 |
| Nathan G. Brower | ▼ Sell | Open Market | 12,015 | $262K | 5/21/2026 |
| Nathan G. Brower | ▲ Buy | Grant | 9,001 | $0 | 5/15/2026 |
| Kevin R. Herbert | ▲ Buy | Grant | 8,326 | $0 | 5/15/2026 |
| Robert D. Straus | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Rong Yang | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Curtis Kopf | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Tess Roering | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Steven J. Fasching | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Heidi Wissmiller | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Bryant J. Yates | ▲ Buy | Grant | 8,753 | $0 | 5/15/2026 |
| Katie May | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 |
| Erich A. Fritz | ▲ Buy | Grant | 9,226 | $0 | 5/15/2026 |
| Kenneth G. Romanzi | ▲ Buy | Grant | 33,753 | $0 | 5/15/2026 |
| Kevin Gregory Fuller | ▲ Buy | Grant | 8,984 | $0 | 5/15/2026 |
| Jonathan David Lanoy | ▲ Buy | Grant | 6,107 | $0 | 5/15/2026 |
| Daniel C. Norman | ▲ Buy | Grant | 11,377 | $0 | 5/15/2026 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 2,235 | $0 | 5/5/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 645 | $17K | 5/5/2026 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 1,526 | $0 | 5/5/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 441 | $11K | 5/5/2026 |
| Erich A. Fritz | ▲ Buy | Option Exercise | 1,372 | $0 | 5/5/2026 |
| Erich A. Fritz | ▼ Sell | Tax Withholding | 469 | $12K | 5/5/2026 |
| Kevin Gregory Fuller | ▲ Buy | Option Exercise | 1,677 | $0 | 5/5/2026 |
| Kevin Gregory Fuller | ▼ Sell | Tax Withholding | 573 | $15K | 5/5/2026 |
| Kevin R. Herbert | ▲ Buy | Option Exercise | 1,500 | $0 | 5/5/2026 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 366 | $9K | 5/5/2026 |
| Leslie Shane Jones | ▲ Buy | Option Exercise | 4,004 | $0 | 5/5/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 1,756 | $46K | 5/5/2026 |
| Leslie Shane Jones | ▲ Buy | Option Exercise | 2,484 | $0 | 5/5/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 1,090 | $28K | 5/5/2026 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 460 | $0 | 5/5/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 133 | $3K | 5/5/2026 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 1,565 | $0 | 5/5/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 452 | $12K | 5/5/2026 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 1,133 | $0 | 5/5/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 327 | $8K | 5/5/2026 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 2,448 | $0 | 5/5/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 707 | $18K | 5/5/2026 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 2,716 | $0 | 5/5/2026 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 1,634 | $0 | 5/5/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 472 | $12K | 5/5/2026 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 2,014 | $0 | 5/5/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 582 | $15K | 5/5/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 784 | $20K | 5/5/2026 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 2,124 | $0 | 5/5/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 613 | $16K | 5/5/2026 |
| Kenneth G. Romanzi | ▲ Buy | Option Exercise | 13,118 | $0 | 5/5/2026 |
| Kenneth G. Romanzi | ▼ Sell | Tax Withholding | 5,753 | $149K | 5/5/2026 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 2,448 | $0 | 5/5/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 707 | $18K | 5/5/2026 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 2,716 | $0 | 5/5/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 784 | $20K | 5/5/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 1,289 | $35K | 4/20/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 3,512 | $95K | 4/20/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 951 | $26K | 4/20/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 1,567 | $42K | 4/20/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 1,567 | $42K | 4/20/2026 |
| Bryant J. Yates | ▼ Sell | Open Market | 19,516 | $475K | 3/13/2026 |
| Daniel C. Norman | ▼ Sell | Open Market | 15,383 | $377K | 3/13/2026 |
| Daniel C. Norman | ▼ Sell | Gift | 3,610 | $88K | 3/13/2026 |
| Jonathan David Lanoy | ▼ Sell | Open Market | 4,000 | $99K | 3/13/2026 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 917 | $23K | 3/11/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 1,103 | $27K | 3/11/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 953 | $24K | 3/11/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 2,341 | $58K | 3/11/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 1,195 | $30K | 3/11/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 832 | $21K | 3/11/2026 |
| Kevin Gregory Fuller | ▼ Sell | Tax Withholding | 1,497 | $38K | 3/10/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 1,459 | $37K | 3/10/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 1,363 | $34K | 3/10/2026 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 1,163 | $29K | 3/10/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 1,896 | $48K | 3/10/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 1,012 | $25K | 3/10/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 2,847 | $71K | 3/10/2026 |
| Kevin Gregory Fuller | ▼ Sell | Other | 7,965 | — | 3/6/2026 |
| Erich A. Fritz | ▼ Sell | Other | 8,180 | — | 3/6/2026 |
| Kenneth G. Romanzi | ▼ Sell | Other | 29,928 | — | 3/6/2026 |
| Bryant J. Yates | ▼ Sell | Other | 7,761 | — | 3/6/2026 |
| Daniel C. Norman | ▼ Sell | Other | 10,088 | — | 3/6/2026 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 1,086 | $0 | 3/6/2026 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 371 | $9K | 3/6/2026 |
| Kevin R. Herbert | ▲ Buy | Option Exercise | 1,239 | $0 | 3/6/2026 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 368 | $9K | 3/6/2026 |
| Leslie Shane Jones | ▲ Buy | Option Exercise | 2,002 | $0 | 3/6/2026 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 878 | $22K | 3/6/2026 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 312 | $8K | 3/6/2026 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 1,541 | $0 | 3/6/2026 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 527 | $13K | 3/6/2026 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 1,317 | $0 | 3/6/2026 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 450 | $11K | 3/6/2026 |
| Erich A. Fritz | ▲ Buy | Grant | 8,180 | $205K | 3/6/2026 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 913 | $0 | 3/6/2026 |
| Kevin Gregory Fuller | ▲ Buy | Grant | 7,965 | $200K | 3/6/2026 |
| Kenneth G. Romanzi | ▲ Buy | Grant | 29,928 | $750K | 3/6/2026 |
| Bryant J. Yates | ▲ Buy | Grant | 7,761 | $194K | 3/6/2026 |
| Leslie Shane Jones | ▲ Buy | Grant | 11,798 | $296K | 3/6/2026 |
| Jonathan David Lanoy | ▲ Buy | Grant | 5,415 | $136K | 3/6/2026 |
| Nathan G. Brower | ▲ Buy | Grant | 7,250 | $182K | 3/6/2026 |
| Daniel C. Norman | ▲ Buy | Grant | 10,088 | $253K | 3/6/2026 |
| Jonathan David Lanoy | ▼ Sell | Other | 5,415 | — | 3/6/2026 |
| Leslie Shane Jones | ▼ Sell | Other | 11,798 | — | 3/6/2026 |
| Kevin R. Herbert | ▼ Sell | Other | 7,124 | — | 3/6/2026 |
| Nathan G. Brower | ▼ Sell | Other | 7,250 | — | 3/6/2026 |
| Kevin R. Herbert | ▲ Buy | Grant | 7,124 | $179K | 3/6/2026 |
| Bryant J. Yates | ▼ Sell | Open Market | 1,700 | $38K | 12/12/2025 |
| Erich A. Fritz | ▲ Buy | Grant | 10,760 | $225K | 12/8/2025 |
| Nathan G. Brower | ▼ Sell | Gift | 1,500 | $31K | 11/24/2025 |
| Jonathan David Lanoy | ▼ Sell | Open Market | 5,000 | $102K | 11/18/2025 |
| Daniel C. Norman | ▼ Sell | Gift | 3,571 | $74K | 11/17/2025 |
| Nathan G. Brower | ▼ Sell | Open Market | 3,800 | $79K | 11/14/2025 |
| Daniel C. Norman | ▼ Sell | Open Market | 8,884 | $182K | 11/12/2025 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 354 | $5K | 11/4/2025 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 2,716 | $0 | 11/4/2025 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 780 | $11K | 11/4/2025 |
| Gonzalez Martin A. | ▲ Buy | Option Exercise | 2,885 | $0 | 11/4/2025 |
| Gonzalez Martin A. | ▼ Sell | Tax Withholding | 833 | $11K | 11/4/2025 |
| Gonzalez Martin A. | ▲ Buy | Option Exercise | 2,910 | $0 | 11/4/2025 |
| Gonzalez Martin A. | ▼ Sell | Tax Withholding | 840 | $12K | 11/4/2025 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 1,008 | $0 | 11/4/2025 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 285 | $4K | 11/4/2025 |
| Nathan G. Brower | ▲ Buy | Option Exercise | 2,235 | $0 | 11/4/2025 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 700 | $10K | 11/4/2025 |
| Leslie Shane Jones | ▲ Buy | Option Exercise | 4,004 | $0 | 11/4/2025 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 1,756 | $24K | 11/4/2025 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 230 | $0 | 11/4/2025 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 79 | $1K | 11/4/2025 |
| Jonathan David Lanoy | ▲ Buy | Option Exercise | 1,566 | $0 | 11/4/2025 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 535 | $7K | 11/4/2025 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 1,224 | $0 | 11/4/2025 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 354 | $5K | 11/4/2025 |
| Daniel C. Norman | ▲ Buy | Option Exercise | 2,716 | $0 | 11/4/2025 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 784 | $11K | 11/4/2025 |
| Bryant J. Yates | ▲ Buy | Option Exercise | 1,224 | $0 | 11/4/2025 |
| Kenneth G. Romanzi | ▲ Buy | Grant | 102,881 | $1.5M | 11/4/2025 |
| Kevin Gregory Fuller | ▼ Sell | Tax Withholding | 1,261 | $20K | 9/26/2025 |
| Bryant J. Yates | ▼ Sell | Open Market | 4,672 | $78K | 8/29/2025 |
| Bryant J. Yates | ▼ Sell | Open Market | 5,000 | $84K | 8/26/2025 |
| Jonathan David Lanoy | ▼ Sell | Open Market | 5,000 | $83K | 8/13/2025 |
| Nathan G. Brower | ▼ Sell | Open Market | 9,996 | $165K | 8/13/2025 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 1,738 | $26K | 7/21/2025 |
| Gonzalez Martin A. | ▼ Sell | Tax Withholding | 3,781 | $56K | 7/21/2025 |
| Terrence Moorehead | ▼ Sell | Tax Withholding | 9,302 | $138K | 7/21/2025 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 1,703 | $25K | 7/21/2025 |
| Comstock Tracee | ▼ Sell | Tax Withholding | 1,235 | $18K | 7/21/2025 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 341 | $5K | 7/21/2025 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 1,491 | $22K | 7/21/2025 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 2,854,607 | $32.7M | 6/27/2025 |
| Steven J. Fasching | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Heidi Wissmiller | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Curtis Kopf | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Tess Roering | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Rong Yang | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Katie May | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Robert D. Straus | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 |
| Comstock Tracee | ▼ Sell | Tax Withholding | 834 | $12K | 3/11/2025 |
| Daniel C. Norman | ▼ Sell | Tax Withholding | 1,406 | $20K | 3/11/2025 |
| Gonzalez Martin A. | ▼ Sell | Tax Withholding | 1,290 | $19K | 3/11/2025 |
| Terrence Moorehead | ▼ Sell | Tax Withholding | 6,180 | $90K | 3/11/2025 |
| Kevin R. Herbert | ▼ Sell | Tax Withholding | 980 | $14K | 3/11/2025 |
| Nathan G. Brower | ▼ Sell | Tax Withholding | 991 | $14K | 3/11/2025 |
| Leslie Shane Jones | ▼ Sell | Tax Withholding | 2,343 | $34K | 3/11/2025 |
| Jonathan David Lanoy | ▼ Sell | Tax Withholding | 833 | $12K | 3/11/2025 |
| Bryant J. Yates | ▼ Sell | Tax Withholding | 1,201 | $17K | 3/11/2025 |
| Kevin Gregory Fuller | ▲ Buy | Grant | 13,148 | $194K | 3/10/2025 |
| Bryant J. Yates | ▲ Buy | Grant | 12,810 | $189K | 3/10/2025 |
| Gonzalez Martin A. | ▲ Buy | Grant | 13,758 | $203K | 3/10/2025 |
| Terrence Moorehead | ▲ Buy | Grant | 49,389 | $728K | 3/10/2025 |
| Kevin R. Herbert | ▲ Buy | Grant | 11,760 | $173K | 3/10/2025 |
| Nathan G. Brower | ▲ Buy | Grant | 11,966 | $176K | 3/10/2025 |
| Jonathan David Lanoy | ▲ Buy | Grant | 8,882 | $131K | 3/10/2025 |
| Leslie Shane Jones | ▲ Buy | Grant | 19,474 | $287K | 3/10/2025 |
| Daniel C. Norman | ▲ Buy | Grant | 16,651 | $245K | 3/10/2025 |
| Comstock Tracee | ▲ Buy | Grant | 8,890 | $131K | 3/10/2025 |
| Katie May | ▲ Buy | Grant | 1,766 | $25K | 2/4/2025 |
| Leslie Shane Jones | ▲ Buy | Grant | 9,925 | $150K | 12/19/2024 |
| Daniel C. Norman | ▼ Sell | Gift | 3,600 | $59K | 11/27/2024 |
| Steven J. Fasching | ▲ Buy | Grant | 2,869 | $50K | 11/11/2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 2,300 | $30K | 10/15/2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 1,300 | $17K | 10/14/2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 1,580 | $21K | 10/11/2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 3,000 | $40K | 10/10/2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ▼ Sell | Open Market | 1,816 | $24K | 10/9/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.